Arena Pharmaceuticals, Inc. (ARNA) stock is lower by -12.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ARNA stock a score of 35 out of a possible 100. That rank is mainly influenced by a short-term technical score of 13. ARNA's rank also includes a long-term technical score of 22. The fundamental score for ARNA is 70. In addition to the average rating from Wall Street analysts, ARNA stock has a mean target price of $97.43. This means analysts expect the stock to rise 66.60% over the next 12 months.
Arena Pharmaceuticals, Inc. (ARNA) Stock Falls -2.32% This Week: Is It a Good Pick?
ARNA has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on ARNA!